Entropy Technologies, LP Ardelyx, Inc. Transaction History
Entropy Technologies, LP
- $952 Billion
- Q3 2024
A detailed history of Entropy Technologies, LP transactions in Ardelyx, Inc. stock. As of the latest transaction made, Entropy Technologies, LP holds 14,312 shares of ARDX stock, worth $71,130. This represents 0.01% of its overall portfolio holdings.
Number of Shares
14,312
Previous 32,606
56.11%
Holding current value
$71,130
Previous $242 Million
59.19%
% of portfolio
0.01%
Previous 0.03%
Shares
3 transactions
Others Institutions Holding ARDX
# of Institutions
220Shares Held
141MCall Options Held
1.08MPut Options Held
2M-
Janus Henderson Group PLC London, X021.5MShares$107 Million0.08% of portfolio
-
Black Rock Inc. New York, NY17.6MShares$87.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.6MShares$67.6 Million0.0% of portfolio
-
State Street Corp Boston, MA12.1MShares$60.3 Million0.0% of portfolio
-
Macquarie Group LTD Australia, C38.95MShares$44.5 Million0.07% of portfolio
About ARDELYX, INC.
- Ticker ARDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 154,636,000
- Market Cap $769M
- Description
- Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...